Monday, December 07 | Post-Acute Care

New COVID-19 ICD-10 Codes Effective January 1, 2021

By Lisa Selman-Holman, Vice President, Clinical Services, McBee

Updated 11/20/2023

As we saw in April 2020, there again will be an expedited release of ICD-10-CM codes related to COVID-19 effective January 1, 2021.

The following COVID ICD-10 Codes will go into effect on January 1, 2021:

  • New Pneumonia ICD 10 Code Change: J12.82 Pneumonia due to coronavirus disease 2019 – To avoid potential under-recording of pneumonia due to COVID-19.
  • New MIS ICD 10 Code Change: M35.81 Multisystem inflammatory syndrome (MIS) – Code first COVID-19, U07.1; Code also if applicable exposure to SARS-CoV-2 infection (Z20.822) use additional codes for associated complications.
  • M35.89 Other specified systemic involvement of connective tissue 
  • Z11.52, Encounter for screening for COVID-19 – This code will only be used if asymptomatic otherwise use the appropriate symptom code. 
  • Z86.16, Personal history of COVID-19 
  • Z20.822, Contact with and (suspected) exposure to COVID-19 

Changes to COVID ICD-10 Codes:

The prior changes around COVID-19 code assignment left confusion due to changes in guidance from the interim guidance issued in April 2020 to the release of the official ICD-10-CM coding guidelines effective October 1, 2020. Here are a few key items to keep in mind:

  • These ICD-10 code guidelines and conventions related to COVID-19 will not be found in the Chapter 22 specifics even though the code is found there, but rather in Chapter 1 of the official guidelines with other infectious diseases.
  • Per the official FY2021 guidelines manifestations, a COVID-19 diagnosis must be confirmed or so stated per the physician, which is different than the interim guidance released when U07.1 COVID-19 was first introduced with the unprecedented April 2020 release.

Home health agencies should contact their EMR vendors to make sure the new expedited COVID ICD-10 Codes for 2023 will be updated in the clinical and billing software applications in time for the January 1 roll out. Individuals responsible for code assignment should make sure they understand the guidelines and conventions related to assignment of these new codes. Here are a few tips for ICD-10 coding for COVID-19:

  • Coders cannot assign COVID-19 U07.1 for “suspected”, “possible” or “inconclusive” terminology. In this case assign the appropriate signs and symptoms.
  • Keep in mind the physician’s diagnostic statement is sufficient for code assignment.
  • If COVID-19 meets the definition of principle diagnosis it will be listed primary followed by additional codes for the manifestations. Keep in mind this will not apply to certain coding scenarios such as infections associated with sepsis, lung transplants, newborns, pregnancy, childbirth and the puerperium. In these situations, reference the appropriate code chapter for sequencing guidance.
  • When the patient presents with manifestations of COVID-19 and the reason for the admission is the manifestation, you will sequence U07.1 COVID-19 primary. Remember, per the official FY2021 guidelines, manifestations of COVID-19 must be confirmed or so stated per the physician.
  • For those who are being treated for a COVID-19 manifestation but no longer have the acute COVID-19 infection, assign the manifestation code followed by B94.8 Sequelae of other specified infectious and parasitic disease. Remember in this scenario a personal history code is not appropriate since the patient is clearly receiving treatment for a residual of COVID-19.

Examples of ICD-10 Code assignment changes related to COVID-19:

New COVID-19 ICD-10 Codes Effective Jan 1 2021 

 

More resources for information on new ICD-10 codes and guidance:

 

Meet the Author

Lisa Selman-Holman
Lisa Selman-Holman · Vice President, Clinical Services, McBee

From the CareThreads Blog

Target Denials Before They Happen: The Role of AI in Revenue Cycle Management

Target Denials Before They Happen: The Role of AI in Revenue Cycle Management

Tuesday, October 20 | Post-Acute Care,Revenue Cycle/Billing,Thought Leadership

Denials have historically been treated as a billing problem. A claim is denied. The billing team investigates. Someone tracks down documentation, contacts a payer, corrects the issue, resubmits the claim and waits. If the claim is denied again, the cycle starts over. But here’s the thing: once a denial reaches billing, the work is no longer about preventing the issue. It is about recovering from it.

Read the blog
A New National Benchmark for Personal Care Is Beginning to Take Shape

A New National Benchmark for Personal Care Is Beginning to Take Shape

Monday, October 19 | Post-Acute Care,Thought Leadership

A potentially important shift in personal care took effect on July 1, 2026. Under the Centers for Medicare & Medicaid Services (CMS) Medicaid Access Rule, states were required to begin publicly reporting standardized fee-for-service payment information for several home- and community-based services, including personal care, home health aide, homemaker and habilitation services. At first glance, this may look like another technical Medicaid reporting requirement. Its longer-term significance could be much greater.

Read the blog
The Hidden Gaps Driving Audit Risk in Post-Acute Care

The Hidden Gaps Driving Audit Risk in Post-Acute Care

Wednesday, October 07 | Post-Acute Care,Thought Leadership

Organizations can no longer afford to approach audit readiness as the responsibility of one department. It requires a connected strategy that spans the entire revenue cycle and helps identify risk before it becomes an audit finding.

Read the blog